(Reuters) World stocks nudged higher on Monday on hopes for a coronavirus vaccine after AstraZeneca resumed its phase-3 trial, but the gains were limited as caution prevailed before a host of central bank meetings this week.
Sterling, which has been hurt by renewed Brexit turmoil, firmed before a key vote on British Prime Minister Boris Johnson’s plan to break international law by breaching parts of the Brexit divorce treaty with the European Union.
European stock markets opened higher but drifted back down. U.S. stock futures held firm in a positive sign for the Wall Street open, supported by M&A news. Read more…..
Chart of the Day
Scientists’ goal is to develop a vaccine that is safe and effective.